Los Angeles-based Bionaut Labs, which designs remote-controlled micro-robots to deliver treatments to the midbrain, said it has raised $43.2 million in Series B funding. The round was led by Khosla Ventures. The funding will be focused on treatments for malignant glioma brain tumors and Dandy-Walker Syndrome, the startup said.